|
Tyrkalska SD, Candel S, Pedoto A, Garcia-Moreno D, Alcaraz-Perez F, Sanchez-Ferrer A, Cayuela ML, Mulero V. Zebrafish models of COVID-19. FEMS Microbiol Rev. 2023 Jan 16;47(1):fuac042. doi: 10.1093/femsre/fuac042. PubMed PMID: 36323404; PubMed Central PMCID: PMC9841970.
AÑO: 2023; IF: 10.1
|
36323404
|
Hernandez-Silva D, Canton-Sandoval J, Martinez-Navarro FJ, Perez-Sanchez H, de Oliveira S, Mulero V, Alcaraz-Perez F, Cayuela ML. Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. Int J Mol Sci. 2022 Sep 9;23(18):10468. doi: 10.3390/ijms231810468. PubMed PMID: 36142384; PubMed Central PMCID: PMC9499634.
AÑO: 2022; IF: 5.6
|
|
Hernandez-Silva D, Alcaraz-Perez F, Perez-Sanchez H, Cayuela ML. Virtual screening and zebrafish models in tandem, for drug discovery and development. Expert Opin Drug Discov. 2023 Jul-Dec;18(8):903-915. doi: 10.1080/17460441.2022.2147503. Epub 2022 Nov 30. PubMed PMID: 36383405.
AÑO: 2023; IF: 6.0
|
|
Peris I, Romero-Murillo S, Martinez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, Jimenez-Munoz M, Alburquerque-Prieto C, Torres-Lopez A, Fresquet V, Martinez-Climent JA, Mateos MC, Cayuela ML, Narla G, Odero MD, Vicente C. Activation of the PP2A-B56alpha heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation. Blood. 2023 Mar 2;141(9):1047-1059. doi: 10.1182/blood.2022016466. PubMed PMID: 36455198; PubMed Central PMCID: PMC10023731.
AÑO: 2023; IF: 21.0
|
|
Candel S, Tyrkalska SD, Perez-Sanz F, Moreno-Docon A, Esteban A, Cayuela ML, Mulero V. Analysis of 16S rRNA Gene Sequence of Nasopharyngeal Exudate Reveals Changes in Key Microbial Communities Associated with Aging. Int J Mol Sci. 2023 Feb 18;24(4):4127. doi: 10.3390/ijms24044127. PubMed PMID: 36835535; PubMed Central PMCID: PMC9960676.
AÑO: 2023; IF: 4.9
|